Max Healthcare Institute Ltd up by 6.61%: Market Update By Espresso


Espresso shot of the day – Max Healthcare Institute Ltd up by 6.61 percent

August 17, 2021
Espresso shot of the day – Max Healthcare Institute Ltd up by 6.61 percent

MAX HEALTHCARE INSTITUTE LTD 344.30 (+6.61%) BSE – INE027H01010 | 17TH AUGUST 2021

Max Healthcare is India’s leading provider of healthcare services, which is committed to the highest standards of clinical excellence and patient care supported by latest technology and cutting-edge research. MHIL has a metro-centric presence consisting of a network of 17 healthcare facilities, including 11 state-of-the-art tertiary and quaternary care hospitals, one secondary care hospital and five OPD and day care centres. Out of the total network, nine hospitals and five medical centres are located in Delhi, Mumbai and the NCR region. The Max network includes all the hospitals and medical centres owned and operated by the company and its subsidiaries, and partner healthcare facilities. Two of its hospitals in Mohali and Bathinda are under PPP arrangement with the Government of Punj. In addition to its core hospital business, Max Healthcare has two SBUs – Max@Home and MaxLab. Max@Home is a platform that provides health and wellness services at home and MaxLab offers diagnostic services to patients outside its network.

Recent Drivers

  • On Aug 11, 2021, on debt reduction plan, Abhay Soi, Chairman and MD of Max Healthcare Institute, said, “We believe there will be significant debt reduction within this current quarter and hopefully by next quarter, we will be a debt-free company.”
  • On Aug 11, 2021, on CapEx, Abhay Soi said, “Currently, we have an operating maintenance CapEx of about Rs 120 crores a year, we have very little interest cost left, so you will see a huge amount of free cashflows within the year itself. Our CapEx plans are about Rs 1,500-1,700 crores over the next four years. We intend to use our residual free cashflows as well as our ability to raise debt to look at inorganic growth and acquisitions.”
  • On Aug 10, 2021, the net profit of Max Healthcare Institute reported at Rs 146.92 crores in the quarter ended June 2021, up 146.75% as against net loss of Rs 314.25 crores during the previous quarter ended June 2020.
  • On Aug 10, 2021, the sales of Max Healthcare Institute rose 290.28% to Rs 1000.17 crores in the quarter ended June 2021 as against Rs 256.27 crores during the previous quarter ended June 2020.
  • On Aug 10, 2021, the board of Max Healthcare Institute at its meeting held on Aug 10, 2021, has approved to infuse up to Rs 150 crores in one of the subsidiary companies of the company [that is, Radiant Life Care Mumbai (Radiant Mumbai)] by way of investment in equity / preference shares / loan in one or more tranches, and the said investment/loan by the company would be within the limits.
  • On June 21, 2021, Max Healthcare Institute launched an artificial intelligence (AI) powered device integrated patient-monitoring framework, claimed to be the first in the country. Max Healthcare has launched the service in collaboration with digital health solutions provider MyHealthcare.
(Sources: Moneycontrol, Business Standard, CNBC TV 18, Business Today)

Technical Force*

  • S&P BSE 500 month till date gain up by 0.3%
  • Traded on all-time-high value of 349
  • 3 months average volume of BSE: 4,29,691
  • Quantity traded: 4,45,535 | Deliverable quantity: 97,417 (21.87%)
  • Stock price has jumped more than 240% from one-year low level: 101.65 (Sept 1, 2020)
  • Daily RSI (14) is in Overbought territory today
  • 52-week-high: 349 | 52-week-low: 101.65

Key Pivot  (Yearly)










Pivot Point










Fibonacci Pivot










Today’s Close




10 DAY


20 DAY


50 DAY


200 DAY


Some Key Ratios (Source: BSE)

Market Cap: 33,257.49 crores

PE: 242.51

OPM%: 30.17

ROE%: 2.31

Promoters holding%: 70.46

Prev. Close: 322.95

*Chart And Technical Force data taken from the Binge desktop app.

The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Sharekhan comtrade bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Sharekhan Comtrade Private Limited is under no obligation to update the information in this document from time-to-time.

Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.